A successful palliative care intervention for cancer pain refractory to intrathecal analgesia.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 22652136.
- Also identified by DOI 10.1016/j.jpainsymman.2011.07.010 and PMC identifier 3859449.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intrathecal delivery of opioid medications has been increasingly used to treat cancer pain that is refractory to conventional oral opioid therapy. We present a patient with complex and refractory cancer pain who failed both oral and intrathecal opioid therapy but responded to the interdisciplinary palliative care intervention in the acute palliative care unit. His morphine equivalent daily dose decreased by 94% over a 10-day period, and he had better pain control and improved function. This case highlights the importance of addressing and treating the psychosocial distress that contributes to the total pain expression.
Medical subject headings
- Neoplasms
- Pain
- Pain Management
- Intractable Pain
- Palliative Care
- Patient Care Team